Tumor cells isolated from immunocompetent mice displayed reduced expression of NKG2D ligand H60 and increased MHC class I expression compared with tumor cells isolated from mice treated with IFN-γ-specific neutralizing monoclonal antibody (mAb) [82]. This evidence concerns the gene KLRK1 and neoplasm.